Eyenovia Inc. (NASDAQ: EYEN)
$1.16
+0.0900 ( +8.41% ) 1.3M
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
Market Data
Open
$1.16
Previous close
$1.07
Volume
1.3M
Market cap
$71.89M
Day range
$1.05 - $1.19
52 week range
$0.50 - $2.57
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 56 | Jun 04, 2024 |
8-k | 8K-related | 15 | May 16, 2024 |
10-q | Quarterly Reports | 66 | May 15, 2024 |
8-k | 8K-related | 15 | May 15, 2024 |
ars | Annual reports | 1 | May 06, 2024 |
def | Proxies and info statements | 6 | May 03, 2024 |
10-k/a | Quarterly Reports | 15 | Apr 26, 2024 |
pre | Proxies and info statements | 6 | Apr 23, 2024 |
8-k | 8K-related | 17 | Apr 10, 2024 |
8-k | 8K-related | 14 | Apr 09, 2024 |